Use of Nitric Oxide Producer L-Arginine during Infusion Therapy of Experimental Hemorrhagic Shock

被引:2
作者
Grishina, G. V. [1 ]
Gerbut, K. A. [1 ]
Remizova, M. I. [1 ]
Selivanov, E. A. [1 ]
机构
[1] Fed Med & Biol Agcy, Russian Res Inst Hematol & Transfusiol, Dept Blood Substitutes & Components, St Petersburg, Russia
关键词
hemorrhagic shock; circulation; nitric oxide; L-arginine; RESUSCITATION;
D O I
10.1007/s10517-013-1939-1
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Experiments on rats showed that infusion of NO precursor L-arginine before bleeding enhanced their tolerance to hemorrhagic shock. When infused after blood loss as a component of saline solution, L-arginine improved effi ciency of infusion therapy for hemorrhagic shock and increased survival rate of the animals.
引用
收藏
页码:312 / 315
页数:4
相关论文
共 15 条
  • [1] Ischemia/reperfusion injury
    Anaya-Prado, R
    Toledo-Pereyra, LH
    Lentsch, AB
    Ward, PA
    [J]. JOURNAL OF SURGICAL RESEARCH, 2002, 105 (02) : 248 - 258
  • [2] Is resuscitation from hemorrhagic shock limited by blood oxygen-carrying capacity or blood viscosity?
    Cabrales, Pedro
    Tsai, Amy G.
    Intaglietta, Marcos
    [J]. SHOCK, 2007, 27 (04): : 380 - 389
  • [3] Exogenous nitric oxide induces protection during hemorrhagic shock
    Cabrales, Pedro
    Tsai, Amy G.
    Intaglietta, Marcos
    [J]. RESUSCITATION, 2009, 80 (06) : 707 - 712
  • [4] L-arginine protects from pringle manoeuvere of ischemia-reperfusion induced liver injury
    Chattopadhyay, Pronobesh
    Verma, Navneet
    Verma, Anurag
    Kamboj, Tirath
    Khan, Nazam Ali
    Wahi, Arun Kumar
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (05) : 890 - 892
  • [5] The microcirculation as a functional system
    Ellis, CG
    Jagger, J
    Sharpe, M
    [J]. CRITICAL CARE, 2005, 9 (Suppl 4): : S3 - S8
  • [6] The ubiquitous role of nitric oxide in cardioprotection
    Jones, SP
    Bolli, R
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (01) : 16 - 23
  • [7] KARPITSKII V V, 1986, Patologicheskaya Fiziologiya i Eksperimental'naya Terapiya, P74
  • [8] Katsumi Hidemasa, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P204
  • [9] KOCHETYGOV NI, 1982, PROBL GEMATOL PERELI, P24
  • [10] Nitric oxide: A clinical primer
    Levy, RM
    Prince, JM
    Billiar, TR
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : S492 - S495